Robert Burns

Dr. Robert F.
Burns is an Independent Director at Circio Holding ASA and a Chairman at Affibody Medical AB. He is on the Board of Directors at Circio Holding ASA. Dr. Burns was previously employed as a President & Chief Executive Officer by Affitech A/S, a Chairman by Haemostatix Ltd., a President & Chief Executive Officer by Celldex Therapeutics, Inc. (Old), a Chief Executive Officer by 4-Antibody AG, a Principal by ABT Corp, a Principal by Applied Biotech, Inc., a Chief Executive Officer by Celldex Therapeutics, Inc., a Principal by Ligand UK Ltd., a Director-Technology Licensing by Ludwig Institute for Cancer Research Ltd., a Principal by Ogs SA, a Principal by Oxford GlycoSciences Plc, and a Principal by Piramed Ltd. He also served on the board at Targovax Oy.
He received his doctorate degree from the University of Birmingham.